Walgreens Boots Alliance, Inc. - Common Stock (WBA)
9.8900
0.00 (0.00%)
Walgreens Boots Alliance is a global healthcare leader that operates a chain of pharmacies, drugstores, and health and wellness retail outlets
The company is known for providing accessible pharmaceutical services and a wide range of health and beauty products. With a commitment to enhancing the health and well-being of its customers, Walgreens Boots Alliance focuses on delivering innovative healthcare solutions, including pharmacy services, immunizations, and health consultations. Additionally, the company engages in retail pharmacy and wholesale distribution, partnering with various healthcare providers to improve patient outcomes and ensure the availability of essential medications and healthcare products.
NEW YORK - February 4, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQWBA) on behalf of investors that purchased or otherwise acquired Walgreens securities between April 2, 2020 and January 16, 2025 (the “Class Period”).
Today marks a milestone for Walgreens as it looks back on the progress made over the last year since the launch of the Walgreens Deans Advisory Council, formed with the goal of enhancing the pharmacy profession and advancing solutions to attract, recruit and create a dynamic workplace for current and future pharmacists.
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session.
SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Walgreens Boots Alliance, Inc. (NYSEWBA) common stock between April 2, 2020 and January 16, 2025. Walgreens operates as a healthcare, pharmacy, and retail company in the U.S., the United Kingdom, Germany, and internationally.
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Walgreens Boots Alliance, Inc. (“Walgreens” or “the Company”) (NASDAQWBA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
NEW YORK - February 3, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQWBA) on behalf of investors that purchased or otherwise acquired Walgreens securities between April 2, 2020 and January 16, 2025 (the “Class Period”).
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers and acquirers of common stock of Walgreens Boots Alliance, Inc. (NASDAQWBA) between April 2, 2020 and January 16, 2025, both dates inclusive (the “Class Period”). The lawsuit states that Walgreens “operates as a healthcare, pharmacy, and retail company” in the U.S., and internationally.
As to the market, at the moment it is being reactive to tariffs, news of which of course aborted the effort at finishing January on a strong note. It's that basic.
Teva Pharmaceuticals is the world's largest generic drug maker with over 500 generics in its portfolio, but shares sold off on its recent earnings, buying opp?
NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQWBA) between April 2, 2020 and January 16, 2025, inclusive.
Shares of pharmacy chain Walgreens Boots Alliance (NASDAQWBA) fell 17% in the morning session after the company announced it is suspending its dividend for the first time in over 90 years. The move to suspend the dividend is a part of the turnaround efforts to improve the balance sheet by reducing debt and improving free cash flow. Though a cut was expected, a complete suspension of the dividend is a surprise given the company's long history of paying one. Even with this move, the path to positive free cash flow in fiscal 2025 is still murky. Store footprint optimization costs, impending debt maturities, and limited upside in the core business in the near term are headwinds.
Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.
Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.
Wall Street is higher this afternoon and headed for its second consecutive winning week, as investors continue unpack this morning's inflation reading and more major corporate earnings.
